Clinical trial data indicate that atomoxetine is safe and well tolerated for the treatment of ADHD; however, safety data about long-term use (greater than one year) are unavailable. Adverse events ...

People with a history of psychosis often also have attention-deficit/hyperactivity disorder (ADHD). However, treating this ...

OSA Atomoxetine plus oxybutynin demonstrated efficacy in improving upper airway collapsibility, increasing breathing stability, and reducing the threshold for arousal in obstructive sleep apnea.

Review the side-effects of Atomoxetine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Atomoxetine is a potent central norepinephrine uptake inhibitor, currently marketed for treatment of attention-deficit/hyperactivity disorder (ADHD). With the ...

Atomoxetine (Attentrol (25 mg)) is a selective norepinephrine reuptake inhibitor (SNRI), prescribed for Attention deficit hyperactivity disorder (ADHD). It increases the level of norepinephrine in the ...

Please provide your email address to receive an email when new articles are posted on . Apnea-hypopnea index dropped by 42% with receipt of 1-week pimavanserin plus atomoxetine vs. placebo. Larger ...

Reason for posting: As a nonstimulant, atomoxetine is a popular new treatment for attention-deficit hyperactivity disorder (ADHD). However, the US Food and Drug Administration and Health Canada ...

NAPERVILLE, Ill., April 22, 2021 (GLOBE NEWSWIRE) -- OWP Pharmaceuticals, Inc. is a privately held, commercial-stage neuroscience specialty pharmaceutical company, dedicated to developing and ...

Liège, Belgium – 24 October 2023 – 7AM CET – Non-regulated information - Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical needs ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. AD109 combines aroxybutynin and atomoxetine in an oral ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, dosage and administration, and place in therapy of atomoxetine in the ...